Over-expression of receptor activator of nuclear factor-κB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty

被引:48
|
作者
Wang, Chen-Ti [1 ,2 ]
Lin, Yu-Tsan [2 ,3 ]
Chiang, Bor-Luen [2 ,3 ]
Lee, Shiou-Shia [2 ,3 ]
Hou, Sheng-Mou [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Orthoped, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan
关键词
Osteolysis; Arthroplasty; Receptor activator of nuclear factor-kappa B ligand (RANKL); Cytokine; Chemokine; BONE-RESORPTION; OSTEOCLAST DIFFERENTIATION; INTERFACE TISSUE; SYNOVIAL-FLUID; WEAR DEBRIS; OSTEOPROTEGERIN; REPLACEMENT; MACROPHAGES; PROSTHESES; PARTICLES;
D O I
10.1016/j.biomaterials.2009.09.017
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Loosening of total hip arthroplasty (THA) caused by periprosthetic osteolysis induced by ultra-high molecular weight polyethylene (UHMWPE) particles is a major clinical problem. We investigated whether there are differences between loosened THA patients and primary THA patients in (1) receptor activator of nuclear factor-kappa B ligand (RANKL) expression on periprosthetic bone marrow cells; (2) RANKL levels, osteoprotegerin (OPG)/RANKL ratios, the levels of inflammatory cytokines and chemokines in synovial fluid. We used flow cytometric analysis to detect RANKL expression on periprosthetic bone marrow cells. We used enzyme-linked immunoassay and multiplex microsphere-based immunoassay to measure RANKL, OPG, cytokines, and chemokines in synovial fluid. We found loosened THA patients had higher RANKL expression on osteoblastic stromal cells, higher levels of RANKL, interleukin (IL)-6, IL-8, IL-10, interferon-gamma-inducible protein (IP)-10, monocyte chemoattractant protein (MCP)-1, monokine induced by interferon-gamma (MIG), and lower OPG/RANKL ratios in synovial fluid than primary THA patients. There was positive correlation between the levels of IL-6, IL-8, IL-10, IP-10, MCP-1, or MIG and RANKL levels in synovial fluid or RANKL expression on osteoblastic stromal cells. These suggest that UHMWPE particles induce over-expression of RANKL, IL-6, IL-8, IP-10, MCP-1, and MIG in human periprosthetic microenvironment. This results in periprosthetic osteolysis and loosening of THA. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 50 条
  • [31] Differential expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA in periodontal diseases
    Bostanci, N.
    Ilgenli, T.
    Emingil, G.
    Afacan, B.
    Han, B.
    Toz, H.
    Berdeli, A.
    Atilla, G.
    McKay, I. J.
    Hughes, F. J.
    Belibasakis, G. N.
    JOURNAL OF PERIODONTAL RESEARCH, 2007, 42 (04) : 287 - 293
  • [32] Curcumin Inhibits Osteoclastogenesis by Decreasing Receptor Activator of Nuclear Factor-κB Ligand (RANKL) in Bone Marrow Stromal Cells
    Oh, Sora
    Kyung, Tae-Wook
    Choi, Hye-Seon
    MOLECULES AND CELLS, 2008, 26 (05) : 486 - 489
  • [33] Gold Nanoparticles Inhibited the Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclast Formation by Acting as an Antioxidant
    Sul, Ok-Joo
    Kim, Jin-Chun
    Kyung, Tae-Wook
    Kim, Hye-Jin
    Kim, Youn-Young
    Kim, Song-Hee
    Kim, Ji-Soon
    Choi, Hye-Seon
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2010, 74 (11) : 2209 - 2213
  • [34] The relationship between Receptor Activator of Nuclear Factor-κB Ligand (RANKL) gene polymorphism and aortic calcification in Korean women
    Rhee, Eun-Jung
    Yun, Eun-Joo
    Oh, Ki-Won
    Park, Se Eun
    Park, Cheol-Young
    Lee, Won-Young
    Park, Sung-Woo
    Kim, Sun-Woo
    Baek, Ki-Hyun
    Kang, Moo Il
    ENDOCRINE JOURNAL, 2010, 57 (06) : 541 - 549
  • [35] Receptor activator of nuclear factor-kappa B ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis
    Sasaki, A
    Ishikawa, K
    Haraguchi, N
    Mimori, K
    Tanaka, F
    Inoue, H
    Ohta, M
    Kitano, S
    Mori, M
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 51 - 51
  • [36] Distinct gene expression of receptor activator of nuclear factor-κB and rank ligand in the inflammatory response to variant morphologies of UHMWPE particles
    Ren, WP
    Yang, SY
    Fang, HW
    Hsu, S
    Wooley, PH
    BIOMATERIALS, 2003, 24 (26) : 4819 - 4826
  • [37] Colony-Stimulating Factor-1 (CSF-1) Directly Inhibits Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Expression by Osteoblasts
    Wittrant, Y.
    Gorin, Y.
    Mohan, S.
    Wagner, B.
    Abboud-Werner, S. L.
    ENDOCRINOLOGY, 2009, 150 (11) : 4977 - 4988
  • [38] Expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression
    Schubert, Antje
    Schulz, Hiltrud
    Emons, Guenter
    Gruendker, Carsten
    GYNECOLOGICAL ENDOCRINOLOGY, 2008, 24 (06) : 331 - 338
  • [39] Cathepsin g enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-κB ligand
    Wilson, Thomas J.
    Nannuru, Kalyan C.
    Futakuchi, Mitsuru
    Sadanandam, Anguraj
    Singh, Rakesh K.
    CANCER RESEARCH, 2008, 68 (14) : 5803 - 5811
  • [40] Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-κB ligand pathway
    Bendre, MS
    Margulies, AG
    Walser, B
    Akel, NS
    Bhattacharrya, S
    Skinner, RA
    Swain, F
    Ramani, V
    Mohammad, KS
    Wessner, LL
    Martinez, A
    Guise, TA
    Chirgwin, JM
    Gaddy, D
    Suva, LJ
    CANCER RESEARCH, 2005, 65 (23) : 11001 - 11009